Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 19,016 | 13,731 | 17,431 | 11,095 | 10,947 |
| Operating Income | -19,016 | -13,731 | -17,431 | -11,095 | -10,947 |
| Interest Expense | 29 | 29 | 2 | 64 | 29 |
| Other Income | 330 | 433 | 499 | 525 | 163 |
| Pre-tax Income | -18,715 | -13,327 | -16,934 | -10,633 | -10,813 |
| Income Tax | N/A | N/A | -1,310 | N/A | N/A |
| Net Income Continuous | -18,715 | -13,327 | -15,624 | -10,633 | -10,813 |
| Net Income | $-18,715 | $-13,327 | $-15,624 | $-10,633 | $-10,813 |
| EPS Basic Total Ops | -0.69 | -0.49 | -0.58 | -0.38 | -0.52 |
| EPS Basic Continuous Ops | -0.69 | -0.49 | -0.58 | -0.39 | -0.52 |
| EPS Diluted Total Ops | -0.69 | -0.49 | -0.58 | -0.38 | -0.52 |
| EPS Diluted Continuous Ops | -0.69 | -0.49 | -0.58 | -0.39 | -0.52 |
| EBITDA(a) | $-19,096 | $-13,845 | $-17,580 | $-11,179 | $-11,014 |